Blood Substitutes: Possibilities with Nanotechnology

被引:9
作者
Alam, Feroz [1 ]
Yadav, Neha [2 ]
Ahmad, Murad [1 ]
Shadan, Mariyam [1 ]
机构
[1] Aligarh Muslim Univ, Dept Pathol, JN Med Coll, Aligarh 202002, Uttar Pradesh, India
[2] All India Inst Med Sci, New Delhi, India
关键词
Blood substitutes; Polyhemoglobin; Artificial red cells; Nanotechnology; MEMBRANE HEMOGLOBIN NANOCAPSULES; CELLS; ENZYMES;
D O I
10.1007/s12288-013-0309-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nanotechnology deals with molecules in the nanometer (10(-9)) range and is currently being used successfully in the field of medicine. Nanotechnology has important implications in nearly all the branches of medicine and it has all the capabilities to revolutionize the vast field of medicine in future. Nanotechnological advancements have been used for the preparation of artificial hemoglobin. It is formed by assembling the hemoglobin molecules into a soluble complex. A recent approach includes the assembling of this artificial hemoglobin with enzymes such as catalase and superoxide dismutase into a nano-complex. This complex acts as an oxygen carrier as well as an antioxidant in conditions with ischemia-reperfusion injuries.
引用
收藏
页码:155 / 162
页数:8
相关论文
共 35 条
[1]   LINKED FUNCTIONS IN ALLOSTERIC PROTEINS - EXTENSION OF THE CONCERTED (MWC) MODEL FOR LIGAND-LINKED SUBUNIT ASSEMBLY AND ITS APPLICATION TO HUMAN HEMOGLOBINS [J].
ACKERS, GK ;
JOHNSON, ML .
JOURNAL OF MOLECULAR BIOLOGY, 1981, 147 (04) :559-582
[2]  
Aggarwal S, 2012, ANN TROP MED PUBLIC, V5, P50
[3]   THE EFFECT OF PH AND D-GLYCERATE 2,3-BISPHOSPHATE ON THE O-2 EQUILIBRIUM OF NORMAL AND SH(BETA-93)-MODIFIED HUMAN-HEMOGLOBIN [J].
ANTONINI, E ;
CONDO, SG ;
GIARDINA, B ;
IOPPOLO, C ;
BERTOLLINI, A .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1982, 121 (02) :325-328
[4]  
Antonini E, 1971, FRONT BIOL, V21, P189
[5]   INTRACELLULAR ORGANIC PHOSPHATES AS REGULATORS OF OXYGEN RELEASE BY HAEMOGLOBIN [J].
BENESCH, R ;
BENESCH, RE .
NATURE, 1969, 221 (5181) :618-&
[6]   Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion [J].
Carson, JL ;
Noveck, H ;
Berlin, JA ;
Gould, SA .
TRANSFUSION, 2002, 42 (07) :812-818
[7]  
Chaitanya kumar I.S, 2011, ASIAN J TRANSFUS SCI, V5, P68
[8]  
CHANG TMS, 1985, METHOD ENZYMOL, V112, P195
[9]   Analysis of polyethylene-glycol-polylactide nano-dimension artificial red blood cells in maintaining systemic hemoglobin levels and prevention of methemoglobin formation [J].
Chang, TMS ;
Powanda, D .
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY, 2003, 31 (03) :231-247
[10]  
Chang TMS, 1998, TISS ENG, P216